Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma

Cetuximab, a monoclonal antibody against the epidermal growth factor receptor (EGFR), has been successfully used to treat some patients with colorectal cancer and those with head and neck squamous cell carcinoma (HNSCC). For the effective treatment, it is essential to first identify cetuximab-respon...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncogenesis
Hlavní autoři: Kondo, T, Ozawa, S, Ikoma, T, Yang, X-Y, Kanamori, K, Suzuki, K, Iwabuchi, H, Maehata, Y, Miyamoto, C, Taguchi, T, Kiyono, T, Kubota, E, Hata, R-I
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2016
Témata:
Short Communication
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5399171/
https://ncbi.nlm.nih.gov/pubmed/27399917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/oncsis.2016.43
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky